Head-to-head · WeighScore
altRX vs Luci
The verdict
altRX takes it — 71.4/100 to 71/100, but only just.
altRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. altRX is a dual-modality telehealth platform offering compounded GLP-1s plus all four brand-name FDA-approved options — Mounjaro, Ozempic, Wegovy, and Zepbound — the most comprehensive brand-name lineup in… Luci is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | altRX | Luci |
|---|---|---|
| WeighScore | 71.4/100 | 71/100 |
| Grade | C | C |
| Scorecard rank | #92 | #101 |
| Semaglutide | $149/mo (starting dose, compounded) | $99/mo (starting dose, promotional rate, compounded) |
| Tirzepatide | $249/mo (starting dose, compounded) | $145/mo (starting dose, promotional rate, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #92 · C
Strengths
- Offers all four brand-name FDA-approved GLP-1s (Mounjaro, Ozempic, Wegovy, Zepbound) — the most comprehensive brand-name access we've reviewed
- LegitScript Certified with a publicly verifiable seal
- Publishes the FDA compounded-medication disclaimer
- Transparent pricing across all six product tiers (compounded plus four brand-name)
- All-inclusive pricing — consult, prescription, and shipping with no hidden fees
Where it loses points
- States-served list not disclosed
- 503A/503B pharmacy partner not named (only 'multiple USA-certified pharmacies')
- 503A vs 503B designation not specified
- No named medical director
- Corporate physical address not disclosed
Graded #101 · C
Strengths
- Budget-friendly compounded GLP-1 pricing (compounded semaglutide as low as $99/month, tirzepatide as low as $145/month)
- Multiple formats: compounded semaglutide and tirzepatide injections plus oral semaglutide and tirzepatide pill kits
- Upfront pricing with no insurance required and a fast 3-minute questionnaire to start
- Care delivered through DrTelx, an independent US telehealth medical group, with ongoing support and dose optimization
- HIPAA-compliant platform with a large self-reported member base (50,000+)
Where it loses points
- Compounded medications are not FDA-approved for weight loss (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Available only in select U.S. states, and the full state list is not published
- The compounding pharmacy partner is not named
- Headline prices are 'as low as' rates (asterisked) — your actual monthly cost may be higher
- No LegitScript certification displayed; marketing leans heavily on testimonials
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.